Vascular Hyperacetylation is Associated with Vascular Smooth Muscle Dysfunction in a Rat Model of Non-obese Type 2 Diabetes

Overview

Journal Mol Med

Publisher Biomed Central

Specialties General Medicine
Molecular Biology

Date 2022 Mar 9

PMID 35260080

Authors

Maria Alicia Carrillo-Sepulveda

Nicole Maddie

Christina Mary Johnson

Cameron Burke

Osina Lutz

Bamwa Yakoub

Benjamin Kramer

Dhandevi Persand

Affiliations

Soon will be listed here.

Abstract

Background: Advanced type 2 diabetes mellitus (T2DM) accelerates vascular smooth muscle cell (VSMC) dysfunction which contributes to the development of vasculopathy, associated with the highest degree of morbidity of T2DM. Lysine acetylation, a post-translational modification (PTM), has been associated with metabolic diseases and its complications. Whether levels of global lysine acetylation are altered in vasculature from advanced T2DM remains undetermined. We hypothesized that VSMC undergoes dysregulation in advanced T2DM which is associated with vascular hyperacetylation.

Methods: Aged male Goto Kakizaki (GK) rats, a non-obese murine model of T2DM, and age-matched male Wistar rats (control group) were used in this study. Thoracic aortas were isolated and examined for measurement of global levels of lysine acetylation, and vascular reactivity studies were conducted using a wire myograph. Direct arterial blood pressure was assessed by carotid catheterization. Cultured human VSMCs were used to investigate whether lysine acetylation participates in high glucose-induced reactive oxygen species (ROS), a crucial factor triggering diabetic vascular dysfunction.

Results: The GK rats exhibited marked glucose intolerance as well as insulin resistance. Cardiovascular complications in GK rats were confirmed by elevated arterial blood pressure and reduced VSMC-dependent vasorelaxation. These complications were correlated with high levels of vascular global lysine acetylation. Human VSMC cultures incubated under high glucose conditions displayed elevated ROS levels and increased global lysine acetylation. Inhibition of hyperacetylation by garcinol, a lysine acetyltransferase and p300/CBP association factor (PCAF) inhibitor, reduced high glucose-induced ROS production in VSMC.

Conclusion: This study provides evidence that vascular hyperacetylation is associated with VSMC dysfunction in advanced T2DM. Understanding lysine acetylation regulation in blood vessels from diabetics may provide insight into the mechanisms of diabetic vascular dysfunction, and opportunities for novel therapeutic approaches to treat diabetic vascular complications.

Citing Articles

Ginsenoside Rb Reduces Hyper-Vasoconstriction Induced by High Glucose and Endothelial Dysfunction in Rat Aorta.

Park J, Shin Y, Kim U, Seol G Pharmaceuticals (Basel). 2023; 16(9).

PMID: 37765046 PMC: 10536350. DOI: 10.3390/ph16091238.

Functions and mechanisms of protein lysine butyrylation (Kbu): Therapeutic implications in human diseases.

Xue Q, Yang Y, Li H, Li X, Zou L, Li T Genes Dis. 2023; 10(6):2479-2490.

PMID: 37554202 PMC: 10404885. DOI: 10.1016/j.gendis.2022.10.025.

Survival of Myocardial Infarction Patients with Diabetes Mellitus at the Invasive Era (Results from the Városmajor Myocardial Infarction Registry).

Skoda R, Nemes A, Barczi G, Vago H, Ruzsa Z, Edes I J Clin Med. 2023; 12(3).

PMID: 36769565 PMC: 9917755. DOI: 10.3390/jcm12030917.

Diabetes and Its Cardiovascular Complications: Potential Role of the Acetyltransferase p300.

Di Pietrantonio N, Di Tomo P, Mandatori D, Formoso G, Pandolfi A Cells. 2023; 12(3).

PMID: 36766773 PMC: 9914144. DOI: 10.3390/cells12030431.

Oxidative Regulation of Vascular Ca1.2 Channels Triggers Vascular Dysfunction in Hypertension-Related Disorders.

Hu X, Zhang L Antioxidants (Basel). 2022; 11(12).

PMID: 36552639 PMC: 9774363. DOI: 10.3390/antiox11122432.

References

Cai X, Zhang Y, Li M, Wu J, Mai L, Li J . Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020; 370:m2297. PMC: 7362233. DOI: 10.1136/bmj.m2297. View

Sowers J, Epstein M, Frohlich E . Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001; 37(4):1053-9. DOI: 10.1161/01.hyp.37.4.1053. View

Li P, Ge J, Li H . Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease. Nat Rev Cardiol. 2019; 17(2):96-115. DOI: 10.1038/s41569-019-0235-9. View

Kazuyama E, Saito M, Kinoshita Y, Satoh I, Dimitriadis F, Satoh K . Endothelial dysfunction in the early- and late-stage type-2 diabetic Goto-Kakizaki rat aorta. Mol Cell Biochem. 2009; 332(1-2):95-102. DOI: 10.1007/s11010-009-0178-2. View

Carrillo-Sepulveda M, Spitler K, Pandey D, Berkowitz D, Matsumoto T . Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats. J Mol Med (Berl). 2015; 93(12):1341-54. DOI: 10.1007/s00109-015-1318-7. View

Ren H, Yang Y, Wang F, Yan Y, Shi X, Dong K . Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19. Cardiovasc Diabetol. 2020; 19(1):58. PMC: 7213552. DOI: 10.1186/s12933-020-01035-2. View

Shi Y, Vanhoutte P . Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes. 2017; 9(5):434-449. DOI: 10.1111/1753-0407.12521. View

Holman R, Paul S, Bethel M, Matthews D, Neil H . 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359(15):1577-89. DOI: 10.1056/NEJMoa0806470. View

Iyer A, Fairlie D, Brown L . Lysine acetylation in obesity, diabetes and metabolic disease. Immunol Cell Biol. 2011; 90(1):39-46. DOI: 10.1038/icb.2011.99. View

10.

Faries P, Rohan D, Takahara H, Wyers M, Contreras M, Quist W . Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg. 2001; 33(3):601-7. DOI: 10.1067/mva.2001.111806. View

11.

Rizza R . Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy. Diabetes. 2010; 59(11):2697-707. PMC: 2963523. DOI: 10.2337/db10-1032. View

12.

King G . The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes. Ann Med. 1996; 28(5):427-32. DOI: 10.3109/07853899608999103. View

13.

Sun H, Ren X, Xiong X, Chen Y, Zhao M, Wang J . NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension. Cell Death Dis. 2017; 8(10):e3074. PMC: 5680591. DOI: 10.1038/cddis.2017.470. View

14.

Kramer B, Franca L, Zhang Y, de Andrade Paes A, Gerdes A, Carrillo-Sepulveda M . Western diet triggers Toll-like receptor 4 signaling-induced endothelial dysfunction in female Wistar rats. Am J Physiol Heart Circ Physiol. 2018; 315(6):H1735-H1747. DOI: 10.1152/ajpheart.00218.2018. View

15.

Wannamethee S, Shaper A, Whincup P, Lennon L, Sattar N . Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med. 2011; 171(5):404-10. DOI: 10.1001/archinternmed.2011.2. View

16.

Carrillo-Sepulveda M, Panackal A, Maracheril R, Maddie N, Patel M, Ojamaa K . Triiodothyronine Reduces Vascular Dysfunction Associated with Hypertension by Attenuating Protein Kinase G/Vasodilator-Stimulated Phosphoprotein Signaling. J Pharmacol Exp Ther. 2019; 371(1):88-94. DOI: 10.1124/jpet.119.260471. View

17.

Hjortbak M, Hjort J, Povlsen J, Jensen R, Stottrup N, Laursen M . Influence of diabetes mellitus duration on the efficacy of ischemic preconditioning in a Zucker diabetic fatty rat model. PLoS One. 2018; 13(2):e0192981. PMC: 5825060. DOI: 10.1371/journal.pone.0192981. View

18.

Petrie J, Guzik T, Touyz R . Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018; 34(5):575-584. PMC: 5953551. DOI: 10.1016/j.cjca.2017.12.005. View

19.

Di Tomo P, Alessio N, Falone S, Pietrangelo L, Lanuti P, Cordone V . Endothelial cells from umbilical cord of women affected by gestational diabetes: A suitable in vitro model to study mechanisms of early vascular senescence in diabetes. FASEB J. 2021; 35(6):e21662. DOI: 10.1096/fj.202002072RR. View

20.

Moodahadu L, Dhall R, Zargar A, Bangera S, Ramani L, Katipally R . Tight glycemic control and cardiovascular effects in type 2 diabetic patients. Heart Views. 2015; 15(4):111-20. PMC: 4348983. DOI: 10.4103/1995-705X.151084. View